Skip to main content

Table 4 The comparison of variables in the treatment group (PRP + splint) at the beginning and end of study

From: Safety and efficacy of platelet-rich plasma in treatment of carpal tunnel syndrome; a randomized controlled trial

Variables Group Number Mean SD P value
VAS Before 21 6.82 1.24 < 0.001
After 21 4.02 1.92
MedSNAP PL Before 21 4.25 0.52 0.005
After 21 4.12 0.63
MedCMAP OL Before 21 4.13 0.53 0.472
After 21 4.15 0.52
SSS Before 21 2.43 0.73 < 0.001
After 21 1.72 0.52
FSS Before 21 2.36 0.83 0.003
After 21 1.83 0.73